DocGo Inc. 8-K Summary
Business Context and Reporting Period
DocGo Inc. filed a Form 8-K on December 1, 2021, under Item 7.01 to furnish an update regarding its full-year 2021 revenue and Adjusted EBITDA guidance. The filing references an accompanying press release, Exhibit 99.1, but the press release text is not included in the provided filing content.
Financial Metrics
- Revenue: The filing states that management updated full-year 2021 revenue guidance, but it does not provide a clear guidance amount in the available text.
- Adjusted EBITDA: The filing states that management updated full-year 2021 Adjusted EBITDA guidance, but it does not provide a clear guidance amount in the available text.
- Profit, cash flow, margins, debt, and liquidity: No related financial figures or discussion are provided in the available filing text.
Material Changes, Outlook, and Risks
- The material disclosure is an update to full-year 2021 revenue and Adjusted EBITDA guidance.
- The filing text does not specify whether the guidance was raised, lowered, or reaffirmed, nor does it provide the underlying assumptions, management commentary, risks, contingencies, or unusual items.
- The disclosure was furnished under Regulation FD and is not deemed filed for purposes of the Exchange Act or incorporated by reference into other filings, except where expressly stated.
Key Facts for Investors to Verify
- Review Exhibit 99.1 for the specific full-year 2021 revenue and Adjusted EBITDA guidance amounts.
- Verify whether the guidance represented an increase, reduction, or reaffirmation versus prior guidance.
- Review management’s stated assumptions, operational drivers, risks, and any non-GAAP reconciliation for Adjusted EBITDA.
- Note that the company’s common stock traded under DCGO and its warrants under DCGOW on Nasdaq as of the filing date.